[ET Net News Agency, 21 May 2026] INNOGEN-B (02591) fell 10% to HK$12.25.
It hits an intra-day low of HK$12.23, and an intra-day high of HK$13.77. The total shares traded was 3.46 million, with a value of HK$44.34m. The active buy/sell ratio is 37:63, with net selling turnover of HK$11.05m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$1.23m, with volume weighted average price of HK$12.841. KGI ASIA accounts for greatest net responsive selling turnover of HK$1.15m, with volume weighted average price of HK$12.814. The stock has fallen a combined 14.6% over the past 2 consecutive trading days.
Basic Information| Nominal | 12.250 | % Chg | -9.99% |
| High | 13.770 | Low | 12.230 |
| Shares Tr | 3.46m | Turnover | 44.34m |
| 10-D SMA | 13.730 | %H.V | 153.580 |
| 20-D SMA | 14.316 | VWAP | 12.813 |
| 50-D SMA | 18.488 | RSI14 | 37.673 |
Status: Active buy/sell ratio is 37:63, with net selling turnover of HK$11.05m, falling a combined 14.6% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 12.25 | -9.99 |
| INNOVENT BIO (01801) | 81.60 | +2.77 |
| EVEREST MED (01952) | 32.00 | +1.07 |
| XTALPI (02228) | 8.02 | +1.52 |
| WUXI BIO (02269) | 33.22 | +0.24 |
| JOINN (06127) | 20.86 | +6.27 |
| BEONE MEDICINES (06160) | 184.50 | +1.93 |
| SKB BIO (06990) | 451.80 | +3.39 |
| AKESO (09926) | 120.50 | +4.78 |
| REMEGEN (09995) | 88.70 | +3.38 |
(ed)
Nominal 
